Donor-transmitted malaria after heart transplant managed successfully with artesunate.

Sabé, N; González-Costello, J; Oriol, I; Sánchez-Salado, J C; Ortega, S; Oliver, E; Manito, N; Carratalà, J

Sabé, N; González-Costello, J; Oriol, I; Sánchez-Salado, J C; Ortega, S; Oliver, E; Manito, N; Carratalà, J.

Affiliation

Sabé N; Infectious Disease Service, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) - Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.

Transpl Infect Dis ; 16(6): 999-1002, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25272242

Subject(s)

Antimalarials/therapeutic use; Artemisinins/therapeutic use; Heart Transplantation/adverse effects; Malaria, Falciparum/drug therapy; Malaria, Falciparum/transmission; Artesunate; Humans; Male; Middle Aged; Plasmodium falciparum/isolation & purification; Tissue Donors

Key words

artesunate; erythropheresis; heart transplant; severe malaria; solid organ transplantation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Heart Transplantation / Malaria, Falciparum / Artemisinins / Antimalarials Limits: Humans / Male / Middle aged Language: En Journal: Transpl Infect Dis Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google